French Guiana Wellness Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.

Press releases published on May 6, 2026

ABLi Therapeutics Appoints Industry Veteran Dr. Rachelle S. Doody to its Board of Directors
Annexon to Present at the Bank of America Securities Health Care Conference 2026
IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences
Pathos AI Acquires Majority Stake in DeuterOncology to Advance Next-Generation MET Inhibitor Identified by Pathos Foundry Platform
Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026
Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update
Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference
Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
UroGen Reports ZUSDURI™ Revenue More Than Doubled Quarter-over-Quarter and Provides First Quarter 2026 Financial Results and Highlights
PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results
CRYSVITA® Now Publicly Reimbursed for the Treatment of Adults with XLH in Four Provinces and Federal Non-Insured Health Benefits Program
CRYSVITA(MC) est désormais remboursé par les régimes publics pour le traitement des adultes atteints d’XLH dans quatre provinces et dans le cadre du Programme fédéral des services de santé non assurés
Erasca to Present at the Bank of America Securities Health Care Conference
Brain Cancer Canada Awards $75,000 to Groundbreaking Pediatric Brain Cancer Study at University of Manitoba Targeting Hard-to-Treat DMG-P Tumours
PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026
Kura Oncology to Participate in Bank of America Securities Healthcare Conference
BEYONTTRA™ (acoramidis), the First Near-Complete TTR Stabilizer (≥90%), Approved by ANVISA to Treat ATTR-CM in Brazil
Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response
Cronos Expands Pre-Roll Portfolio with Spinach STIX®
Bioventus Reports First Quarter Financial Results

Share this page:

Sign up for:

French Guiana Wellness Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.